Skip to main content

Top selling pharma drugs in 2016

PharmaCompass provided an interesting overview of the top selling drugs in 2016. Abbvie's Humira generated record sales of US $16.078 billion in 2016, followed by Gilead's Harvoni (US $9.081 billion) and Amgen/Pfizer's Enbrel (US $8.875 billion).

S. No

Product

Active Ingredient

Main Therapeutic Indication

Company

2016 Revenue in Millions (USD)

2015 Revenue in Millions (USD)

Sales Difference in Millions (USD)

1

Humira

Adalimumab

Immunology (Organ Transplant, Arthritis etc.)

Abbvie

16,078

14,012

2,066

2

Harvoni

Ledipasvir and Sofosbuvir

Infectious Diseases (HIV, Hepatitis etc.)

Gilead

9,081

13,864

(4,783)

3

Enbrel

Etanercept

Immunology (Organ Transplant, Arthritis etc.)

Amgen/Pfizer Inc.

8875

8697

178

4

Remicade

 Infliximab

Immunology (Organ Transplant, Arthritis etc.)

Johnson & Johnson/Merck & Co

8,234

8,355

(121)

5

MabThera/Rituxan

Rituximab 

Oncology

Roche

7227

6974.55

252

6

Revlimid

Lenalidomide

Oncology

Celgene

6,974

5,801

1,173

7

Avastin

Bevacizumab

Oncology

Roche

6,715

6,617

98

8

Herceptin

Trastuzumab

Oncology

Roche

6,714

6,473

242

9

Lantus

Insulin Glargine

Diabetes

Sanofi

6,057

6,773

(717)

10

Prevnar/Prevenar 13

Pneumococcal 7-Valent Conjugate

Anti-bacterial

Pfizer Inc.

5,718

6,246

(528)

11

Xarelto

Rivaroxaban

Cardiovascular Diseases

Bayer/Johnson & Johnson

5,392

4,255

1,137

12

Eylea

Aflibercept

Ophthalmology

Regeneron Pharmaceuticals, Inc./Bayer

5,046

3,978

1,068

13

Lyrica

Pregabalin

Neurological/Mental Disorders

Pfizer Inc.

4,966

4,839

127

14

Neulasta

Pegfilgrastim

Blood Disorders

Amgen

4,648

4,715

(67)

15

Seretide/Advair

Salmeterol

Respiratory Disorders

GlaxoSmithKline

4,252

4,491

(239)

16

Copaxone

Glatiramer

Neurological/Mental Disorders

Teva

4,223

4,023

200

17

Sovaldi

Sofosbuvir

Infectious Diseases (HIV, Hepatitis etc.)

Gilead

4,001

5,276

(1,275)

18

Tecfidera

Dimethyl Fumarate

Neurological/Mental Disorders

Biogen

3,968

3,638

330

19

Januvia

Sitagliptin 

Diabetes

Merck & Co

3,908

3,864

44

20

Opdivo

Nivolumab

Oncology

Bristol-Myers Squibb

3,774

942

2,832

 

How can we help you?